Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis

Digestive Diseases and Sciences

Volumn 52, Issue 8, 2007, Pages 1995-2005

  Töx, Ulrich ^a,b   Scheller, Ingo ^a   Kociok, Norbert ^b   Kern, Michael André ^a   Klanac, Dejan ^a   Daudi, Sharif Mohammed ^a   Laue, Oliver ^a   Schirmacher, Peter ^a   Goeser, Tobias ^a   Schulte, Sigrid ^a   Steffen, Hans Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Angiotensin II receptor type 1; Bile duct occlusion; Candesartan; Experimental liver cirrhosis; Fibrogenesis; Rats; Smad2 protein; Transforming growth factor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; COLLAGEN TYPE 1; GELATINASE A; MESSENGER RNA; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT OBSTRUCTION; CONTROLLED STUDY; DISEASE COURSE; EARLY INTERVENTION; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING;

EID: 34347380343     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9133-1     Document Type: Article

References (52)

1. Kawaguchi H, Kitabatake A (1995) Renin-angiotensin system in failing heart. J Mol Cell Cardiol 27:201-209
2. Weber KT (1997) Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin Nephrol 17:467-491
3. Michel JB, Nicolletti A, Arnal JF (1995) Left ventricular remodelling following experimental myocardial infarction. Eur Heart J 16(Suppl I):49-57
4. Wolf G, Mueller E, Stahl RA, Ziyadeh FN (1993) Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92:1366-1372
5. Border WA, Noble NA (1998) Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 31:181-188
6. Kagami S, Border WA, Miller DE, Noble NA (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437
7. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, Angus PW (2001) Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 35:376-385
8. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H (2001) Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34:745-750
9. Bataller R, Sancho-Bru P, Gines P, Lora JM, Al-Garawi A, Sole M, Colmenero J, Nicolas JM, Jimenez W, Weich N, Gutierrez-Ramos JC, Arroyo V, Rodes J (2003) Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125:117-125
10. Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE (2001) Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 121:148-155
11. Wei H, Li D, Lu H, Zhan Y, Wang Z, Huang X, Pan Q, Xu Q (2000) Effects of angiotensin II receptor blockade on hepatic fibrosis in rats. Zhonghua Gan Zang Bing Za Zhi 8:302-304
12. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472
13. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, Brenner DA (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112:1383-1394
14. Leung PS, Suen PM, Ip SP, Yip CK, Chen G, Lai PB (2003) Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regul Pept 116:61-69
15. Shimizu S, Satomura K, Aramaki T, Katsuta Y, Takano T, Omoto Y (2003) Hepatic chymase level in chronic hepatitis: co-localization of chymase with fibrosis. Hepatol Res 27:62-66
16. Bissell DM, Roulot D, George J (2001) Transforming growth factor beta and the liver. Hepatology 34:859-867
17. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H (2000) Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32:247-255
18. Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H (1999) Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 96:2345-2349
19. Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita A, Shimizu K, Ohashi H (2000) A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 11:33-42
20. Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296:1646-1647
21. Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753-791
22. Theret N, Lehti K, Musso O, Clement B (1999) MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells. Hepatology 30:462-468
23. Gonzalez-Abraldes J, Albillos A, Banares R, Del Arbol LR, Moitinho E, Rodriguez C, Gonzalez M, Escorsell A, Garcia-Pagan JC, Bosch J (2001) Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 121:382-388
24. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F, Rodes J (1981) Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 11:221-229
25. Schneider AW, Kalk JF, Klein CP (1999) Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 29:334-339
26. Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, Stoffel-Wagner B, Hofer U, Caselmann WH, Sauerbruch T (2001) Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology 121:389-395
27. Speer CA, Ferrentino N (2002) Angiotensin receptor antagonists in portal hypertension: fog over paradise. Gastroenterology 122:1543
28. Sanyal AJ (2001) Angiotensin receptor blockade and portal hypertension: paradise gained and paradise lost. Gastroenterology 121:487-490
29. Tuncer I, Ozbek H, Ugras S, Bayram I (2003) Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis. Exp Toxicol Pathol 55:159-166
30. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A (1998) Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 31:342-348
31. Nickenig G, Strehlow K, Baumer AT, Baudler S, Wassmann S, Sauer H, Bohm M (2000) Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression. Br J Pharmacol 131:795-803
32. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D (1997) Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26:643-649
33. Gerling B, Becker M, Waldschmidt J, Rehmann M, Schuppan D (1996) Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis. J Hepatol 25:79-84
34. Welch WJ, Deng X, Snellen H, Wilcox CS (1995) Validation of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats. Am J Physiol 268:F175-F178
35. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA (1994) A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20:349-355
36. Jamall IS, Finelli VN, Que Hee SS (1981) A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 112:70-75
37. Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG, Riecken EO, Schuppan D (2000) An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 118:1169-1178
38. Morrison TB, Weis JJ, Wittwer CT (1998) Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24:954-958, 960,962
39. Nickenig G, Laufs U, Schnabel P, Knorr A, Paul M, Bohm MP (1997) Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats. Br J Pharmacol 121:134-140
40. Wei HS, Li DG, Lu HM, Zhan YT, Wang ZR, Huang X, Zhang J, Cheng JL, Xu QF (2000) Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4). World J Gastroenterol 6:540-545
41. Nickenig G, Harrison DG (2002) The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis. II. AT(1) receptor regulation. Circulation 105:530-536
42. Kai H, Griendling KK, Lassegue B, Ollerenshaw JD, Runge MS, Alexander RW (1994) Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension 24:523-527
43. Poo JL, Estanes A, Pedraza-Chaverri J, Cruz C, Perez C, Huberman A, Uribe M (1997) [Chronology of portal hypertension, decreased sodium excretion, and activation of the renin-angiotensin system in experimental biliary cirrhosis]. Rev Invest Clin 49:15-23
44. Svegliati-Baroni G, Saccomanno S, van Goor H, Jansen P, Benedetti A, Moshage H (2001) Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver 21:1-12
45. Shah V, Cao S, Hendrickson H, Yao J, Katusic ZS (2001) Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol Gastrointest Liver Physiol 280:G1209-G1216
46. Rockey DC, Chung JJ, McKee CM, Noble PW (1998) Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 27:86-92
47. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW (2002) Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123:1667-1676
48. Hao J, Wang B, Jones SC, Jassal DS, Dixon IM (2000) Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol 279:H3020-H3030
49. Wamsley-Davis A, Padda R, Truong LD, Tsao CC, Zhang P, Sheikh-Hamad D (2004) AT1A-mediated activation of kidney JNK1 and SMAD2 in obstructive uropathy: preservation of kidney tissue mass using candesartan. Am J Physiol Renal Physiol 287:F474-F480
50. Kamada Y, Tamura S, Kiso S, Fukui K, Doi Y, Ito N, Terui Y, Saito T, Watanabe H, Togashi H, Kawata S, Matsuzawa Y (2003) Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells. Hepatol Res 25:296-305
51. Debernardi-Venon W, Barletti C, Alessandria C, Marzano A, Baronio M, Todros L, Saracco G, Repici A, Rizzetto M (2002) Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension. Dig Dis Sci 47:401-404
52. Heller J, Shiozawa T, Trebicka J, Hennenberg M, Schepke M, Neef M, Sauerbruch T (2003) Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats. Eur J Clin Invest 33:1006-1012